Study of histological modifications, of pro-apoptotic effects and of modifications in apoptosis regulators observed after stopping 5-ASA treatment in patients with inactive ulcerative colitis (clinical and endoscopic remission) taking 5-ASA.
Phase of Trial: Phase IV
Latest Information Update: 20 Apr 2012
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 24 Sep 2009 New trial record.